Safety and Efficacy of Repeat Use of Picato 0.05% in the Treatment of Anogenital Warts

Trial Profile

Safety and Efficacy of Repeat Use of Picato 0.05% in the Treatment of Anogenital Warts

Completed
Phase of Trial: Phase II

Latest Information Update: 08 May 2017

At a glance

  • Drugs Ingenol mebutate (Primary)
  • Indications Warts
  • Focus Adverse reactions
  • Sponsors LEO Pharma
  • Most Recent Events

    • 03 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 13 Nov 2015 Planned end date changed from 1 Oct 2015 to 1 Nov 2015, as reported by ClinicalTrials.gov.
    • 13 Nov 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Nov 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top